GlassScriptPhysician profile
Rahul Sharma
NPI 1356634489
$12,566.01
in general payments reported to CMS, 2019-2025
24 companies · $3,613 in 2025
The $3,613 reported for 2025 was more than what 81% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,246 · 2020: $1,328 · 2021: $740 · 2022: $3,596 · 2023: $462 · 2024: $1,581 · 2025: $3,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,521 · Travel and Lodging: $1,634 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,521.38 |
| Travel and Lodging | $1,634.32 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,368.42 | 2019-2025 | Triclip |
| Silk Road Medical, INC. | $2,174.83 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Applied Medical Resources Corporation | $1,500.00 | 2025 | Stealth Soft/Fibra, Stealth Clamps |
| W. L. Gore & Associates, INC. | $1,180.48 | 2020-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Penumbra, INC. | $1,157.86 | 2024-2025 | Indigo System, Penumbra System |
| Cook Medical LLC | $1,090.92 | 2020-2023 | Zenith, Zenith Spiral-Z, Zenith Alpha |
| Endologix LLC | $848.21 | 2020-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Medtronic Vascular, INC. | $655.67 | 2019 | |
| Shockwave Medical, INC | $373.68 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $293.36 | 2019-2021 | |
| Boston Scientific Corporation | $223.16 | 2019-2025 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cardiovascular Systems INC. | $133.11 | 2020-2021 | |
| Smith+Nephew, INC. | $120.70 | 2020 | |
| Davol INC. | $87.27 | 2023 | Phasix Mesh |
| Edwards Lifesciences Corporation | $69.26 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspiremd LTD | $53.27 | 2025 | Cguard Prime Carotid Stent System |
| Janssen Pharmaceuticals, INC | $45.18 | 2019-2022 | |
| Abbvie INC. | $40.93 | 2023-2024 | Alloderm |
| Medtronic, INC. | $39.13 | 2022-2024 | Endurant Iis |
| Cardiva Medical, INC. | $30.41 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bolton Medical INC | $28.02 | 2024 | Treo Abdominal Stent-Graft System |
| Angiodynamics, INC. | $26.79 | 2019 | |
| Bard Peripheral Vascular, INC. | $19.35 | 2024 | Rotarexs 6 F X 135 Cm |
| Intuitive Surgical, INC. | $6.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.